UK – The Guardian: Demand grows for UK ministers to reclassify psilocybin for medical research

UK – The Guardian: Demand grows for UK ministers to reclassify psilocybin for medical research
CANNANNEW REPORT

The Guardian reports Conservative drug reformers and leading psychiatrists are urging ministers to reclassify the psychedelic compound psilocybin so that researchers can explore its potential as a medicine. The same demand is being made by people suffering from cluster headaches – which involve severe pain that existing drugs do little to relieve – amid evidence that psilocybin can help reduce both the condition’s physical and mental impact. Psilocybin, the active ingredient in magic mushrooms, is currently a schedule one drug – the most tightly controlled – under the Misuse of Drugs Act. Campaigners want it downgraded to schedule two to facilitate more studies into its efficacy as a treatment for cluster headaches. Three world-renowned British psychiatrists have written to Sajid Javid, the health secretary, and Kit Malthouse, the crime and policing minister at the Home Office, urging a rethink. Prof Allan Young, Prof Karl Friston and Prof Simon Wessely want the ministers to commission Sir Chris Whitty, the chief medical officer for England, “to assess the evidence for the harms and utility of psilocybin with a view to rescheduling this promising medicine and experimentally useful compound at the earliest opportunity”. Wessely has advised the government on mental health policy and led an independent review, commissioned by then prime minister Theresa May, into the Mental Health Act. Read more at    https://www.theguardian.com/science/2022/mar/08/demand-grows-for-uk-ministers-to-reclassify-psilocybin-for-medical-research  

Excerpt only …
READ MORE BELOW
Source : UK – The Guardian: Demand grows for UK ministers to reclassify psilocybin for medical research

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.